Stent or bypass surgery for coronary artery disease?

September 26, 2002

An international study in this week's issue of The Lancet highlights how patients given bypass surgery for blocked or narrowed coronary arteries are less likely to require further intervention than patients given stent-assisted balloon angioplasty. The study also reported an apparent survival benefit for patients given bypass surgery over those given angioplasty.

Results of previous trials comparing coronary angioplasty with coronary artery bypass grafting (CABG) suggest that rates of death or heart attack do not differ between treatment strategies. However, coronary angioplasty is associated with an increased likelihood of the need for additional revascularisation (another, unplanned repeat procedure). The use of stents in addition to balloon angioplasty should reduce the need for additional revascularisation; the aim of the Stent or Surgery (SoS) trial, led by Rodney Stables from the Cardiothoracic Centre, Liverpool, UK, was to compare the effect of stent-assisted coronary angioplasty with CABG.

1000 patients with coronary artery disease from 53 centres in Europe and Canada were randomly assigned to treatment with stent-assisted angioplasty or CABG. After an average two-year follow-up, around 20% of patients given stenting required additional revascularisation compared with only 6% of patients given CABG. Overall, there was a reduction in subsequent heart attack among patients given angioplasty (5%) than those given CABG (8%). There were fewer deaths among patients given CABG (2%) than those given angioplasty (5%).

Rodney Stables comments: "The use of coronary stents has reduced the need for repeat revascularisation when compared with previous studies that used balloon angioplasty, though the rate remains significantly higher that in patients managed with CABG. The apparent reduction in mortality with CABG requires further investigation."

In an accompanying Commentary (p 961), William O'Neill and Cindy Grines from William Beaumont Hospital, Michigan, USA, state how the advent of drug-eluting stents is going to strengthen the case for angioplasty as an alternative to bypass surgery for the treatment of coronary artery disease. They conclude: "Surgery is likely to remain as the preferred choice for complex anatomical subsets. As the safety and durability of angioplasty continues to improve, the gap in choices will continue to narrow."
-end-
Contact: Dr Rodney H Stables, The Cardiothoracic Centre Liverpool,
Thomas Drive,
Liverpool,L14 3PE;UK;
T) 44-151-293-2489;
F) 44-151-293-2254;
E) r.stables@btinternet.com

Dr William O'Neill, Division of Cardiology, Department of Internal Medicine,
William Beaumont Hospital,
Royal Oak, MI 48073, USA ;
T) 248-551-4198;
F) 248-551-2526;
E) woneill@smtpgw.beaumont.edu

Lancet

Related Heart Attack Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Molecular imaging identifies link between heart and kidney inflammation after heart attack
Whole body positron emission tomography (PET) has, for the first time, illustrated the existence of inter-organ communication between the heart and kidneys via the immune system following acute myocardial infarction.

Muscle protein abundant in the heart plays key role in blood clotting during heart attack
A prevalent heart protein known as cardiac myosin, which is released into the body when a person suffers a heart attack, can cause blood to thicken or clot--worsening damage to heart tissue, a new study shows.

New target identified for repairing the heart after heart attack
An immune cell is shown for the first time to be involved in creating the scar that repairs the heart after damage.

Heart cells respond to heart attack and increase the chance of survival
The heart of humans and mice does not completely recover after a heart attack.

A simple method to improve heart-attack repair using stem cell-derived heart muscle cells
The heart cannot regenerate muscle after a heart attack, and this can lead to lethal heart failure.

Mount Sinai discovers placental stem cells that can regenerate heart after heart attack
Study identifies new stem cell type that can significantly improve cardiac function.

Fixing a broken heart: Exploring new ways to heal damage after a heart attack
The days immediately following a heart attack are critical for survivors' longevity and long-term healing of tissue.

Heart patch could limit muscle damage in heart attack aftermath
Guided by computer simulations, an international team of researchers has developed an adhesive patch that can provide support for damaged heart tissue, potentially reducing the stretching of heart muscle that's common after a heart attack.

How the heart sends an SOS signal to bone marrow cells after a heart attack
Exosomes are key to the SOS signal that the heart muscle sends out after a heart attack.

Read More: Heart Attack News and Heart Attack Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.